Press Releases MBX Biosciences, Inc.

Stocks

MBX

US55287L1017

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 12:20:00 2026-06-11 pm EDT			5-day change	1st Jan Change
33.22 ^USD	+7.18%		+7.73%	+5.58%

May. 11	Mbx Biosciences Insider Sold Shares Worth $2,685,515, According to a Recent SEC Filing	MT
May. 11	MBX Biosciences, Inc. - Special Call

Press Releases

Jun. 01	MBX Biosciences to Host Virtual Investor Event to Discuss Once-Weekly Canvuparatide Presentations at ENDO 2026	AQ
May. 26	MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City	AQ
May. 11	MBX Biosciences : May 2026 Obesity Day Presentation – Final	PU
May. 11	MBX Biosciences Provides Obesity Portfolio Update Including Initial Phase 1 Data for MBX 4291 Supporting Potential for Once-Monthly Dosing	AQ
May. 07	MBX Biosciences : Company Overview - May 2026	PU
May. 07	MBX Biosciences Reports First Quarter 2026 Financial Results and Corporate Highlights	AQ
May. 07	MBX Biosciences Announces Appointment of Mark Soued as Chief Commercial Officer and Inducement Grant Award	AQ
Apr. 23	MBX Biosciences to Host In-Person and Virtual Obesity Day on May 11, 2026 to Discuss Expanding Obesity Portfolio	AQ
Apr. 03	MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	AQ
Mar. 12	MBX Biosciences : Company Overview - March 2026	PU
Mar. 12	MBX Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Highlights	AQ
Mar. 10	MBX Biosciences Appoints Karen Basbaum as Chief Business Officer	AQ
Mar. 09	MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism	AQ
Feb. 23	MBX Biosciences to Participate in Upcoming March Investor Conferences	AQ
Feb. 11	MBX Biosciences to Participate in Upcoming Investor Conferences	AQ
Jan. 22	MBX Biosciences Appoints Laurie Stelzer to Board of Directors as Audit Committee Chair	AQ
Jan. 13	MBX Biosciences : Company Overview - January 2025	PU
Jan. 11	MBX Biosciences to Provide 2026 Outlook and Business Update at 44th Annual J.P. Morgan Healthcare Conference	AQ
Dec. 15	MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13	AQ
Nov. 18	MBX Biosciences to Participate in the 37th Annual Piper Sandler Healthcare Conference	AQ
Nov. 06	MBX Biosciences : Company Overview - November 2025	PU
Nov. 06	MBX Biosciences Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights	AQ
25-10-20	MBX Biosciences to Participate in November Investor Conferences	AQ
25-09-29	MBX Biosciences to Participate in the Stifel 2025 Virtual Cardiometabolic Forum	AQ
25-09-24	MBX Biosciences Announces Pricing of Upsized Public Offering	AQ